A20’s linear ubiquitin–binding motif restrains pathogenic activation of Th17 cells and IL-22–driven enteritis
A20, encoded by the TNFAIP3 gene, is a protein linked to Crohn's disease and celiac disease in humans. We now find that mice expressing point mutations in A20's M1-ubiquitin-binding zinc finger 7 (ZF7) motif spontaneously develop proximal enteritis that requires both luminal microbes and T cells. Cellular and transcriptomic profiling reveals expansion of Th17 cells and exuberant expression of IL-17A and IL-22 in intestinal lamina propria of A20ZF7 mice. While deletion of IL-17A from A20ZF7/ZF7 mice exacerbates enteritis, deletion of IL-22 abrogates intestinal epithelial cell hyperproliferation, barrier dysfunction, and alarmin expression. Colonization of adult germ-free mice with microbiota from adult WT specific pathogen-free mice drives duodenal IL-22 expression and duodenitis. A20ZF7/ZF7 Th17 cells autonomously express more RORγt and IL-22 after differentiation in vitro. ATAC sequencing identified an enhancer region upstream of the Il22 gene, and this enhancer demonstrated increased activating histone acetylation coupled with exaggerated Il22 transcription in A20ZF7/ZF7 T cells. Acute inhibition of RORγt normalized histone acetylation at this enhancer. Finally, CRISPR/Cas9-mediated ablation of A20ZF7 in human T cells increases RORγt expression and IL22 transcription. These studies link A20's M1-ubiquitin binding function with RORγt expression, expansion of Th17 cells, and epigenetic activation of IL-22-driven enteritis.
Authors
- Bahram Razani (ORCID: https://orcid.org/0000-0003-4069-8178)
- Eiki Yamashita (ORCID: https://orcid.org/0000-0002-4278-0039)
- Chun Jimmie Ye (ORCID: https://orcid.org/0000-0001-6560-3783)
- Averil Ma (ORCID: https://orcid.org/0000-0003-4817-1258)
- Dorothea Stibor (ORCID: https://orcid.org/0000-0003-2019-5856)
- Rommel Advincula
- Barbara A. Malynn (ORCID: https://orcid.org/0000-0001-6986-1261)
- Hiromichi Shimizu (ORCID: https://orcid.org/0000-0003-3268-0613)
- Xiaofei Sun (ORCID: https://orcid.org/0000-0002-4835-9309)
- Peter J. Turnbaugh (ORCID: https://orcid.org/0000-0002-0888-2875)
- Yang Sun (ORCID: https://orcid.org/0000-0002-9344-8060)
- Min Cheol Kim (ORCID: https://orcid.org/0000-0002-2234-8070)
- Christopher Bowman (ORCID: https://orcid.org/0000-0002-4107-4116)
- Jessie A. Turnbaugh
- Nika Lenci
Institutions
- Gladstone Institutes (US)
- University of California, San Francisco (US)
- Cancer Research And Biostatistics (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1172/jci187499
- Citations
- 1
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Crohn's and Colitis Foundation
- National Institutes of Health